Impact of Chemotherapy Response and Radiation Dose on Overall Survival in Patients With Inoperable Non-small Cell Lung Cancer Treated With Induction Chemotherapy Followed by Concurrent Chemoradiation Therapy

被引:0
|
作者
Grant, J. [1 ]
Gomez, D. [1 ]
Zhuang, Y. [1 ]
Chang, J. [1 ]
Komaki, R. [1 ]
Fossella, F. [1 ]
Gold, K. [1 ]
Liao, Z. [1 ]
Cox, J. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1016/j.ijrobp.2012.07.1581
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:S593 / S593
页数:1
相关论文
共 50 条
  • [31] Survival in 176 patients with inoperable non-small cell lung cancer treated initially with chemotherapy in a district general hospital
    Gerratt, A. H. N.
    Ahmad, S.
    Graham, K.
    Patel, S. P.
    Webb, J. R.
    Stokes, T. C.
    THORAX, 2007, 62 : A35 - A36
  • [32] A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)
    Jain, Anshu K.
    Hughes, Randall S.
    Sandler, Alan B.
    Dowlati, Afshin
    Schwartzberg, Lee S.
    Dobbs, Tracy
    Schlabach, Larry
    Wu, Jean
    Muldowney, Nancy J.
    Choy, Hak
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 722 - 727
  • [33] Stage III Non-Small Cell Lung Cancer Treated Without Concurrent Chemotherapy: What Is the Optimal Radiation Dose?
    Rimner, A.
    Din, S.
    Shaikh, F.
    Foster, A.
    Tyagi, N.
    Aad, S. Abi
    Paik, P.
    Yorke, E. D.
    Chaft, J. E.
    Gelblum, D. Y.
    Rosenzweig, K. E.
    Wu, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S23 - S23
  • [34] Stage III Non-Small Cell Lung Cancer Treated Without Concurrent Chemotherapy: What Is the Optimal Radiation Dose?
    Rimner, A.
    Din, S.
    Shaikh, F.
    Foster, A.
    Tyagi, N.
    Aad, S. Abi
    Paik, P.
    Yorke, E. D.
    Chaft, J. E.
    Gelblum, D. Y.
    Rosenzweig, K. E.
    Wu, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S653 - S654
  • [35] Dose-Escalated Hypofractionated Intensity Modified Radiation Therapy (IMRT) With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer (NSCLC)
    Kim, J.
    Ghosh, S.
    Roa, W. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S545 - S545
  • [36] A Higher Integral Heart Dose Is Associated With Lymphocytopenia in Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy
    Joseph, N.
    McWilliam, A.
    Kennedy, J.
    Faivre-Finn, C.
    Choudhury, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E481 - E481
  • [37] Induction chemotherapy (± radiotherapy) followed by surgery in non-small cell lung cancer
    Quoix, E
    New Advances in Thoracic Oncology: From Scientific Evidence to Optimal Management, 2005, 350 : 169 - 175
  • [38] Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer
    Vokes, EE
    ONCOLOGIST, 2001, 6 : 25 - 27
  • [39] Chemotherapy Dose Intensity and Survival in Non-small Cell Lung Cancer
    Stewart, David J.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) : 971 - 971
  • [40] Concurrent radiochemotherapy with carboplatin and paclitaxel followed by consolidation chemotherapy in patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Serdar, Ozkok
    Dubova, S.
    Guersel, C.
    Yalman, D.
    T Goeksel
    Goker, E.
    LUNG CANCER, 2006, 52 : S41 - S41